Abstract

Marine macroalgae are efficient producers of sulfated polysaccharides. The algal sulfated polysaccharides possess diverse bioactivities and peculiar chemical structures, and represent a great potential source to be explored. In the present study, a heparinoid-active sulfated polysaccharide was isolated from the green alga Cladophora oligoclada. Results of chemical and spectroscopic analyses indicated that the sulfated polysaccharide was composed of →6)-β-d-Galp-(1→, β-d-Galp-(1→, →6)-α-d-Glcp-(1→ and →3)-β-d-Galp-(1→ units with sulfate esters at C-2/C-4 of →6)-β-d-Galp-(1→, C-6 of →3)-β-d-Galp-(1→ and C-3 of →6)-α-d-Glcp-(1→ units. The branches consisting of β-d-Galp-(1→ and →6)-β-d-Galp-(1→ units were located in C-3 of →6)-β-d-Galp-(1→ units. The sulfated polysaccharide exhibited potent anticoagulant activity in vitro and in vivo as evaluated by activated partial thromboplastin time (APTT), thrombin time, and the fibrinogen level. For the APTT, the signal for clotting time was more than 200 s at 100 μg/mL in vitro and at 15 mg/kg in vivo. The obvious thrombolytic activity of the sulfated polysaccharide in vitro was also found. The mechanism analysis of anticoagulant action demonstrated that the sulfated polysaccharide significantly inhibited the activities of all intrinsic coagulation factors, which were less than 1.0% at 50 μg/mL, but selectively inhibited common coagulation factors. Furthermore, the sulfated polysaccharide strongly stimulated the inhibition of thrombin by potentiating antithrombin-III (AT-III) or heparin cofactor-II, and it also largely promoted the inhibition of factor Xa mediated by AT-III. These results revealed that the sulfated polysaccharide from C. oligoclada had potential to become an anticoagulant agent for prevention and therapy of thrombotic diseases.

Highlights

  • Arterial or venous blood clots can result in acute coronary syndrome or venous thromboembolisms, which are the third leading causes of cardiovascular-event related deaths [1,2]

  • Sulfated polysaccharides biosynthesized by marine algae are great potential sources of naturally occurring anticoagulant agents [5]

  • The results reveal that the sulfated polysaccharide has a high potential as a drug or a food supplement for prevention and therapy of thrombotic diseases

Read more

Summary

Introduction

Arterial or venous blood clots can result in acute coronary syndrome or venous thromboembolisms, which are the third leading causes of cardiovascular-event related deaths [1,2]. Anticoagulant drugs represented by heparin have been widely used in the therapy and prophylaxis of thrombosis. Heparin exhibits some side effects, such as thrombocytopenia, hemorrhagic complications, and congenital or acquired antithrombin deficiency invalidation [3]. Commercial manufacturing of heparin relies on pig intestinal or bovine lung tissues as the raw material, whereas these tissues presumably have a high burden of foreign parasites and may limit the use of heparin [4]. It is crucial to search for an alternative source of an anticoagulant agent. Sulfated polysaccharides biosynthesized by marine algae are great potential sources of naturally occurring anticoagulant agents [5].

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.